Bupropion for the treatment of apathy in Huntington's disease: A multicenter, randomised, double-blind, placebo-controlled, prospective crossover trial

Author(s):
Gelderblom, H.; Wustenberg, T.; McLean, T.; Mutze, L.; Fischer, W.; Saft, C.; Hoffmann, R.; Sussmuth, S.; Schlattmann, P.; Duijn, E. van; Landwehrmeyer, B.; Priller, J.
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-03-21
Language
English
Is part of
PLoS ONE (2017), No. 3
hdl
1887/116495
doi
10.1371/journal.pone.0173872